The described KH patient with a heterozygous NEK11 mutation showed glucagon unresponsive hypoglycemia, migraine, cognitive disability, motor impairments, mild hepatopathy, and decreased plasma IGFBP3 (71, 87). This evidence concerns the gene IGFBP3 and migraine disorder.